BridgeMD
A Phase 2 trial to investigate efficacy and safety of vipoglanstat in women with endometriosis
EU CTIS ID: 2025-522452-16-00
What this study is testing
To evaluate the efficacy of vipoglanstat on endometriosis-related NMPP
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- 1. Premenopausal females 18 to <45 years of age at the time of Visit 1.
- 2. Endometriosis diagnosis confirmed and documented within the last 10 years prior to Visit 1 or during Visit 1 based on: 2a. Surgical (via direct visualization or biopsy verified) or 2b. Imaging (ie, endometriotic lesion(s) detected by transvaginal sonography or magnetic resonance imaging [MRI]).
- 3. History of NMPP significantly affecting daily life confirmed at Visit 1.
- 4. The participant reports moderate, severe, or very severe pain during non-menstrual days in the month prior to Visit 2, based on PGA-NMPP.
You likely can't join if
- 1. Chronic pelvic pain that is not judged to be primarily related to endometriosis (eg, chronic pelvic infection, interstitial cystitis, nerve entrapments or neuropathies, non-endometriosis-related pelvic adhesive disease, persistent symptomatic ovarian cyst [eg, dermoid], posttubal ligation, symptomatic hydrosalpinx, and vaginismus).
- 2. Has had more than 2 surgical procedures for endometriosis
The study team makes the final eligibility decision.
Where it's taking place
- United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18-64 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.